Overview
Anacure Medical is a pioneering medical-device company developing a novel stool-diversion system designed to address anorectal disorders. By significantly reducing leakage, lowering bacterial load, and promoting mucosal healing, our technology supports faster recovery, fewer infections and enhanced patient comfort.
Technology
Our solution centres on a temporary rectal sleeve that locally diverts stool passage, enabling the affected tissue to heal under optimal conditions. The system is minimally invasive, designed for straightforward deployment and removal, and built to integrate seamlessly into standard colorectal surgical workflows.
Unmet Need
Postoperative complications in anorectal and colorectal surgery — including leakage, infection and delayed healing — remain a major challenge. Current diversion methods are often invasive, disrupt patient quality of life, and extend hospital time. Anacure addresses this gap with a patient-centric, reversible device that focuses on restoration of normal physiology and tissue integrity.
Competitive Advantage
Unlike conventional diversion techniques, Anacure’s approach is designed to preserve tissue integrity, reduce trauma, and shorten recovery. The system delivers diversion in a way that emphasises gentleness, usability and clinical efficiency, representing a meaningful shift in standard of care for anorectal conditions.
Market & Impact
The global addressable market for anorectal and colorectal disorders spans patients with inflammatory bowel disease (IBD), anal-fistula, colorectal-cancer-related complications, and post-surgical conditions — numbering in the millions annually. Anacure’s solution aims to improve outcomes at scale: better healing, fewer infections, reduced hospitalisation time and lower healthcare-system burden.
Alignment with NGT’s Mission
As part of NGT’s portfolio of early-stage med-tech innovations, Anacure exemplifies the fund’s focus on high-impact medical technologies addressing significant unmet needs. Our technology aligns with NGT’s commitment to health-innovation, inclusion and regional economic advancement.
Team
- Dr. Randa Salalha — CEO & Co-Founder: Biomedical Engineer & Neuroscience Researcher with a robust track record in medical-device development. (לינקדאין)
- Tom Shtendel — CTO: Mechanical Engineer (B.Sc., M.Sc.) with over a decade of experience in end-to-end medical-device innovation. (Anacure Medical)
- Eli Michaeli — Founder & Co-Founder: Mechanical & Systems Engineer with 20+ years in multidisciplinary development across medical, pharma and aerospace industries. (Anacure Medical)
- Michael Mastai — Scientific Leader & Co-Founder: Bioscience background, experienced in medical education, rights advocacy and biomedical research. (Startup Nation Finder)
- Tal Eckerling — Head of Marketing & Co-Founder: Marketing strategist in medical and lifestyle segments with strong experience in IBD community engagement. (Anacure Medical)
Contact info:
Best regards,
Randa Salalha, Ph.D. | LinkedIn
CEO & Co-Founder | Anacure Medical Ltd.
Tel (IL): +972 (50) 906-9657
Email: Randa@anacuremedical.com